Cargando…

Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study

Detalles Bibliográficos
Autores principales: Thomas, Emma, Tomlinson, Sam, Thomas, Siwan, Ward, Suzanne, Daugherty, Claire, Gallardo, Eva, Hill, Christon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647852/
https://www.ncbi.nlm.nih.gov/pubmed/36270792
http://dx.doi.org/10.1136/ejhpharm-2022-003416
_version_ 1785135205159272448
author Thomas, Emma
Tomlinson, Sam
Thomas, Siwan
Ward, Suzanne
Daugherty, Claire
Gallardo, Eva
Hill, Christon
author_facet Thomas, Emma
Tomlinson, Sam
Thomas, Siwan
Ward, Suzanne
Daugherty, Claire
Gallardo, Eva
Hill, Christon
author_sort Thomas, Emma
collection PubMed
description
format Online
Article
Text
id pubmed-10647852
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-106478522022-10-21 Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study Thomas, Emma Tomlinson, Sam Thomas, Siwan Ward, Suzanne Daugherty, Claire Gallardo, Eva Hill, Christon Eur J Hosp Pharm PostScript BMJ Publishing Group 2023-11 2022-10-21 /pmc/articles/PMC10647852/ /pubmed/36270792 http://dx.doi.org/10.1136/ejhpharm-2022-003416 Text en © European Association of Hospital Pharmacists 2023. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle PostScript
Thomas, Emma
Tomlinson, Sam
Thomas, Siwan
Ward, Suzanne
Daugherty, Claire
Gallardo, Eva
Hill, Christon
Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study
title Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study
title_full Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study
title_fullStr Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study
title_full_unstemmed Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study
title_short Treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational UK patient registry study
title_sort treatment of life-threatening digoxin toxicity with digoxin-specific antibody fragments: results from a prospective, non-interventional observational uk patient registry study
topic PostScript
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647852/
https://www.ncbi.nlm.nih.gov/pubmed/36270792
http://dx.doi.org/10.1136/ejhpharm-2022-003416
work_keys_str_mv AT thomasemma treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy
AT tomlinsonsam treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy
AT thomassiwan treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy
AT wardsuzanne treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy
AT daughertyclaire treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy
AT gallardoeva treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy
AT hillchriston treatmentoflifethreateningdigoxintoxicitywithdigoxinspecificantibodyfragmentsresultsfromaprospectivenoninterventionalobservationalukpatientregistrystudy